Concepedia

Alessandro Di Domizio

AD

Statistics

Publications

8

Citations

352

H-Index

8

Active since

2009

Affiliations

University of Milan(Current)

University of Milano-Bicocca

University of Parma

Alessandro Di Domizio is an author at University of Milan specializing in drug discovery, pharmacology, and proteomics.

ORCID

Publications per year

2009–2022

8

Publications

8

3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line

Alessio Malacrida, Mirko Rivara, Alessandro Di Domizio et al. · Bioorganic & Medicinal Chemistry · 2019 · 190 citations

, , +9

First experimental identification of Ras-inhibitor binding interface using a water-soluble Ras ligand

Alessandro Palmioli, Elena Sacco, Sherwin J. Abraham et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 36 citations · Full text

, , +14

Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D

Alessandro Palmioli, Elena Sacco, Cristina Airoldi et al. · Biochemical and Biophysical Research Communications · 2009 · 34 citations · Full text

, , +15

MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines

Alessio Malacrida, Alessandro Di Domizio, Angela Bentivegna et al. · Biology · 2022 · 33 citations · Full text

, , +17

Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target

Silvia Giatti, Alessandro Di Domizio, Silvia Diviccaro et al. · Journal of Medicinal Chemistry · 2021 · 24 citations · Full text

, , +17

1–5 of 8